SCHEMBL3467592

SCHEMBL3467592

NC(=O)CC1Cc2cc(-c3ccc(C(F)(F)F)cc3)ccc2NC1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 6/20 0.52
TDP2 O95551 1/20 0.43
AKT1 P31749 3/20 0.38
CDK2 P24941 2/20 0.38
CDK1 P06493 1/20 0.38
KIT P10721 1/20 0.38
KDR P35968 1/20 0.38
CHRNB2 P17787 1/20 0.37
CHRNA4 P43681 1/20 0.37
KMT2A Q03164 2/20 0.37
DHODH Q02127 1/20 0.36
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRB3 P13945 1/20 0.35
DGAT1 O75907 1/20 0.34
MEN1 O00255 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
CCKAR P32238 1/20 0.34
CCKBR P32239 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3308412 0.90 KIF11 (0.53) KIF11TDP2AKT1CDK2CDK1
SCHEMBL4891219 0.86 KIF11 (0.56) KIF11TDP2AKT1CDK2CDK1
SCHEMBL3468263 0.85 KIF11 (0.53) KIF11TDP2AKT1CDK2CDK1
SCHEMBL3467771 0.85 KIF11 (0.48) KIF11TDP2AKT1CDK2CDK1
SCHEMBL4887887 0.82 KIF11 (0.55) KIF11TDP2AKT1CDK2CDK1
SCHEMBL3467252 0.81 KIF11 (0.53) KIF11TDP2AKT1CDK2CDK1
SCHEMBL3468115 0.80 KIF11 (0.47) KIF11TDP2AKT1CDK2CDK1
SCHEMBL3713898 0.80 KMT2A (0.43) KIF11TDP2KMT2ADGAT1MEN1
SCHEMBL4596144 0.79 KIF11 (0.60) KIF11TDP2AKT1CDK2CDK1
SCHEMBL4594888 0.79 KIF11 (0.56) KIF11TDP2AKT1CDK2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010074807-A1 3, 4-DIHYDROQUINOLIN-2 ( 1H ) -ONE DERIVATIVES AS SODIUM CHANNEL MODULATORS GILEAD PALO ALTO, INC. (US) 2010-07-01 WO disclosed